Viewing Study NCT01014650

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:59 PM
Ignite Modification Date: 2026-01-29 @ 8:10 AM
Study NCT ID: NCT01014650
Status: COMPLETED
Last Update Posted: 2016-02-22
First Post: 2009-11-13
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Single Ascending Dose Safety, Tolerability and Pharmacokinetics Study of GLYX-13 in Normal Volunteers
Sponsor: Naurex, Inc, an affiliate of Allergan plc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None glycine site partial agonist View
None normal volunteers View
None safety in normal volunteers View